Patient-friendly summary
If you read nothing else
Bottom line
Generic stand-alone self-management programs offer only a marginal benefit for chronic musculoskeletal pain — small, clinically unimportant short-term effects on pain and function, with little lasting impact beyond a modest gain in self-efficacy — and may be most useful as one component of a broader, individualized pain-management plan.
Moderate evidencePublished
Evidence hierarchy
Study participants
Adults with chronic musculoskeletal pain (>3 months) receiving generic self-management interventions versus non-self-management control groups; studies conducted in Western Europe, Australia and the United States
Study Summary
This systematic review and meta-analysis pooled 20 randomized controlled trials (3,557 patients) testing generic self-management programs — interventions that teach skills such as problem-solving, goal-setting and decision-making rather than disease-specific techniques — for adults with chronic musculoskeletal pain. Immediately after treatment, there was moderate-quality evidence of statistically significant but clinically unimportant benefits for physical function and pain intensity, both favouring self-management; effects on self-efficacy showed only a trend and physical activity showed no effect. At six-to-thirteen-month follow-up, only self-efficacy retained a statistically significant but clinically insignificant benefit, while physical function, pain and physical activity showed no between-group difference. The authors conclude that generic self-management interventions offer only a marginal benefit and vary widely in content and delivery.
Key Findings
| Finding | Detail | Impact |
|---|---|---|
| Short-term effects on physical function and pain were statistically significant but clinically unimportant | Post-intervention pooled SMD was -0.28 [-0.52, -0.03] for physical function and -0.28 [-0.56, -0.01] for pain intensity, both favouring self-management (moderate-quality GRADE evidence). Re-expressed on clinical scales, this was ~4.12 points on the Pain Disability Index (below the 8.5-point minimal clinically important change) and ~0.48 points on a 0-10 NRS (below the MCID of 2.0). | High |
| Long-term benefit was limited to a small, clinically insignificant gain in self-efficacy | At follow-up (median 12 months) there was moderate-quality evidence of a statistically significant effect on self-efficacy, SMD -0.13 [-0.25, -0.02], equal to ~1.72 points on the PSEQ (0-60) versus a minimal important change of 5.5 points. Physical function, pain intensity and physical activity showed no between-group difference at follow-up. | High |
| No effect on physical activity at any time point | Post-intervention SMD was 0.14 [-0.14, 0.38] (low-quality evidence) and at follow-up 0.15 [-0.07, 0.38]; neither was statistically significant. | Medium |
| Self-efficacy results were too heterogeneous to pool immediately post-intervention | Ten studies reported post-intervention self-efficacy but I2 was 65%, so no overall effect was calculated; four of the comparisons favoured self-management (SMD -0.74 to -0.32) and four showed no effect, yielding low-quality evidence of a trend. | Medium |
| Interventions varied enormously in content and delivery | Across studies the median was 6 face-to-face sessions (range 3-15) and 15 hours of contact (range 2.8-45 h). The mean number of behaviour change techniques was 12.6 (range 5-26); 43 of 93 taxonomy techniques appeared, concentrated in goals/planning (27.8%) and social support (10.6%). | Medium |
Post-intervention pooled SMD was -0.28 [-0.52, -0.03] for physical function and -0.28 [-0.56, -0.01] for pain intensity, both favouring self-management (moderate-quality GRADE evidence). Re-expressed on clinical scales, this was ~4.12 points on the Pain Disability Index (below the 8.5-point minimal clinically important change) and ~0.48 points on a 0-10 NRS (below the MCID of 2.0).
At follow-up (median 12 months) there was moderate-quality evidence of a statistically significant effect on self-efficacy, SMD -0.13 [-0.25, -0.02], equal to ~1.72 points on the PSEQ (0-60) versus a minimal important change of 5.5 points. Physical function, pain intensity and physical activity showed no between-group difference at follow-up.
Post-intervention SMD was 0.14 [-0.14, 0.38] (low-quality evidence) and at follow-up 0.15 [-0.07, 0.38]; neither was statistically significant.
Ten studies reported post-intervention self-efficacy but I2 was 65%, so no overall effect was calculated; four of the comparisons favoured self-management (SMD -0.74 to -0.32) and four showed no effect, yielding low-quality evidence of a trend.
Across studies the median was 6 face-to-face sessions (range 3-15) and 15 hours of contact (range 2.8-45 h). The mean number of behaviour change techniques was 12.6 (range 5-26); 43 of 93 taxonomy techniques appeared, concentrated in goals/planning (27.8%) and social support (10.6%).
Strengths
- Comprehensive multi-database search (PubMed/MEDLINE, CENTRAL, Embase, PsycINFO) plus backward/forward citation tracking and grey-literature sources to limit publication bias
- Pre-registered protocol (PROSPERO CRD42015024417) and GRADE-based rating of evidence quality
- Independent dual review for study selection, data extraction and risk-of-bias assessment with consensus and a third adjudicator
- Effects re-expressed on familiar clinical scales (PDI, NRS, PSEQ) and compared against minimal clinically important change thresholds
- Intervention content systematically catalogued using the Behaviour Change Technique Taxonomy v1, opening the 'black box' of what these programs contain
Limitations
- Substantial methodological heterogeneity in intervention content and outcome measures led to downgrading every comparison for indirectness
- Use of random-effects models made the pooled effects harder to interpret, even after re-expression on clinical scales
- Conclusions reflect average group effects and could not characterize the proportion of patients who respond well, because few studies reported responder analyses
- Some outcomes (self-efficacy post-intervention) were too heterogeneous to pool and were described narratively
- Only studies published in Dutch or English were included; studies solely of osteoarthritis patients and combined/multicomponent programs were excluded, limiting generalizability
Key Takeaways for Patients
What This Means for You
- 01Generic self-management programs — which teach broad skills like goal-setting, problem-solving and decision-making rather than condition-specific exercises — tend to produce only small, short-lived improvements in pain and daily function for people with long-term musculoskeletal pain.
- 02The clearest lasting benefit was a modest gain in self-efficacy (your confidence in managing pain), though even that was small enough that most people may not notice a meaningful difference.
- 03These programs did not reliably increase how physically active people became.
- 04Self-management skills may still be valuable as one part of a broader, individualized pain-management plan rather than as a stand-alone treatment.
- 05Programs differed widely in length and content, so 'self-management' can mean very different things from one clinic to another.
Read the Full Paper
Access the complete peer-reviewed study from European Journal of Pain
View Full Study